Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT07601737 · RECRUITING

Trial details

NCT number: NCT07601737
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma (HNSCC)Head & Neck Cancer Neoadjuvant Therapy

Start date: 2026-04-20
Primary completion: 2028-04-30
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.